BRL-32872
id:
brl-32872-302-14226264
title:
BRL-32872
text:
BRL-32872 is an experimental drug candidate that provides a novel approach to the treatment of cardiac arrhythmia. Being a derivative of verapamil, it possesses the ability to inhibit Ca+2 membrane channels. Specific modifications in hydrogen bonding activity, nitrogen lone pair availability, and molecular flexibility allow BRL-32872 to inhibit K+ channels as well. As such, BRL-32872 is classified as both a class III (K+ blocking) and class IV (Ca+2 blocking) antiarrhythmic agent.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/BRL-32872
date created:
date modified:
2021-05-01T23:27:12Z
main entity:
{"identifier":"Q4836374","url":"https://www.wikidata.org/entity/Q4836374"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/1/1d/BRL-32872.svg","width":512,"height":235}
fields total:
13
integrity:
15